Digital Respiratory Devices Market To Reach $304.28 Billion By 2030

Digital Respiratory Devices Market Growth & Trends

The global digital respiratory devices market size is expected to reach USD 304.28 billion by 2030, registering a CAGR of 28.92% from 2025 to 2030, based on a new report by Grand View Research, Inc. The market growth can be attributed to an increase in the number of people with chronic respiratory diseases (CRDs) such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and lung disorders. Moreover, COVID-19 has prompted a rise in the number of innovative digital devices and systems for respiratory and pulmonary care, which is driving the demand for digital respiratory devices. For instance, in March 2022, Brisbane-based ResApp informed about the positive data that it received from the Covid-19 instant screening test. The coughing sound is used with the help of a smartphone to detect the presence of the COVID-19 virus in the new test.

Furthermore, during the COVID-19 outbreak, several patients were unable to receive consultations and treatments in person. The pandemic demonstrated how serious respiratory illnesses and infections may become if not treated quickly and carefully. As a result of this, in the post-pandemic era, smart inhaler adoption is anticipated to increase as healthcare professionals turn to connected medical devices to ensure that patients receive the best care and consultation possible, regardless of the circumstance.

Additionally, a growing number of technological advancements in the field of digital respiratory devices are scaling up the digital technologies into existing product portfolios to improve the efficiency of medication as well as the management of asthma and COPD. Moreover, recent studies conducted by research experts have shown that smart inhaler technology may be able to resolve this problem and offer patients a simple way to keep up treatment compliance and control symptoms. For example, a 2019 study from the Cleveland Clinic found that COPD patients utilizing Propeller smart inhalers had a significantly lower risk of being admitted to the hospital, with a nearly 35% drop in visits compared to the previous year (2020).

 Request a free sample copy or view report summary: Digital Respiratory Devices Market Report

Digital Respiratory Devices Market Report Highlights

• In 2024, the smart inhalers and nebulizers product segment held the largest revenue share of over 63.97% owing to the prevalence of asthma and other respiratory conditions rising in direct proportion to air pollution levels, which, in turn, drives the demand for smart inhalers and nebulizers.

• In 2024, the COPD indication segment held the largest revenue share of over 51.39%. The growth of the COPD segment can be attributed to people continuing to smoke and longer life expectancies

• The hospital pharmacies distribution channel segment accounted for the largest revenue share of over 38.31% in 2024. The older population is regularly hospitalized in hospitals for various chronic respiratory illnesses, and they obtain medicine from hospital pharmacies for such conditions.

• In 2024, the hospitals end-use segment accounted for the largest revenue share of over 51.32%. The rising rates of chronic respiratory diseases among developing nations and the rising aging population suffering from asthma and COPD are contributing to the segment growth

• In 2024, North America dominated the market with a share of over 47.33% owing to increasing respiratory disorders among the senior population, new amendments in the government regulations such as favorable reimbursement rebates, and well-established healthcare infrastructure.

• The Asia Pacific is projected to register fastest CAGR over the forecast period. This growth can be attributed to growing COPD and asthma incidence rates in China and India.

Digital Respiratory Devices Market Segmentation

Grand View Research has segmented the global digital respiratory devices market report based on product, disease indication, distribution channel, end use, and region:

Digital Respiratory Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Smart Inhalers & Nebulizers

• Sensors & Apps

Digital Respiratory Devices Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Asthma

• COPD

• Other Diseases

Digital Respiratory Devices Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Digital Respiratory Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Homecare Settings

• Other Settings

Digital Respiratory Devices Regional Outlook (Revenue, USD Million, 2018-2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in Digital Respiratory Devices Market

• COHERO Health Inc. (AptarGroup, Inc.)

• Cognita Labs

• adherium

• Amiko Digital Health Limited

• Teva Pharmaceuticals Industries Ltd.

• Propeller Health.

• Novartis AG

• Pneuma Respiratory Inc.

• 3M

• AireHealth, Inc.

• Findair Sp. z o. o.